A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer
Top Cited Papers
- 31 January 2010
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 57 (1), 79-85
- https://doi.org/10.1016/j.eururo.2009.08.025
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparisonBJU International, 2008
- A graphical device to represent the outcomes of a logistic regression analysisThe Prostate, 2008
- Overdiagnosis and overtreatment of early detected prostate cancerWorld Journal of Urology, 2007
- Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East AngliaBritish Journal of Cancer, 2006
- Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for AbnormalEuropean Urology, 2006
- Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for AbnormalJNCI Journal of the National Cancer Institute, 2005
- DEVELOPMENT AND VALIDATION OF A NOMOGRAM PREDICTING THE OUTCOME OF PROSTATE BIOPSY BASED ON PATIENT AGE, DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGENJournal of Urology, 2005
- Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined TumorsJournal of Urology, 2003
- Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mLCancer, 2003